Literature DB >> 1133744

Vehicle effects on ocular drug bioavailability i: evaluation of fluorometholone.

J W Sieg, J R Robinson.   

Abstract

The influences of drug concentration and vehicle composition on the corneal penetration of the steroid fluorometholone were studied in the albino rabbit. Aqueous dosing systems included a saturated solution and 0.1, 0.05, and 0.1% suspensions of micronized fluorometholone. Two different doses of a 0.1% oleaginous ointment were also studied. The results from the 0.1 and 0.5% suspensions show a peak aqueous humor steroid concentration at 30 min and a substantial sustaining effect with these two concentrations. The results also support the belief that moderate dilution of a suspension of a slowly soluble drug may not substantially lower the aqueous humor drug levels or, conversely, that use of a higher concentration suspension may not improve the aqueous humor drug concentration-time profile. The 0.1% suspension and the saturated solution did not produce a sustaining effect. The results demonstrate for the first time that the particles present in a dose of suspension are retained within the cul-de-sac of the eye and contribute significantly to the amount of steroid penetrating the cornea. This finding was confirmed by a study in which the eye was rinsed with saline solution 30 min after instillation of a dose of a 0.05% suspension. The rinsing procedure prematurely terminated the sustaining effect of the suspension. The results of the ointment studies show that partitioning of the lipophilic steroid from the oleaginous vehicle has a greater rate-limiting influence on corneal penetration than the dissolution rate parameter associated with the aqueous suspensions. Peak aqueous humor concentration was not achieved until 3 hr after dosing and was comparable to the 0.1 and 0.05% suspensions. Predosing of the eye with a saturated solution or the 0.1% suspension prior to dosing with ointment overcomes the inability of the ointment to provide adequate drug at short times following dosing. In this case, peak levels were achieved within 60 min and then maintained. The duration of aqueous humor levels and the amount penetrating from the ointment were greater than the suspensions, and these effects are discussed relative to the mechanism. Differences in aqueous humor levels produced by 25- and 50-mg doses of ointment were minimal. A discussion of the results from all studies is presented in the context of present theories regarding the role of the lipophilic epithelial layer of the cornea as a barrier to drug penetration.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1133744     DOI: 10.1002/jps.2600640606

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  10 in total

1.  In vivo ocular availability of ketorolac following ocular instillations of aqueous, oil, and ointment formulations to normal corneas of rabbits: a technical note.

Authors:  Manjusha Malhotra; Dipak K Majumdar
Journal:  AAPS PharmSciTech       Date:  2005-10-24       Impact factor: 3.246

Review 2.  Ocular drug delivery. Pharmacokinetic considerations.

Authors:  R D Schoenwald
Journal:  Clin Pharmacokinet       Date:  1990-04       Impact factor: 6.447

3.  Time course of changes in ocular wavefront aberration after administration of eye ointment.

Authors:  T Hiraoka; T Yamamoto; F Okamoto; T Oshika
Journal:  Eye (Lond)       Date:  2012-07-20       Impact factor: 3.775

4.  In situ gelling gelrite/alginate formulations as vehicles for ophthalmic drug delivery.

Authors:  Yuejiang Liu; Jinpeng Liu; Xiaolin Zhang; Ruodan Zhang; Yongliang Huang; Chunjie Wu
Journal:  AAPS PharmSciTech       Date:  2010-03-31       Impact factor: 3.246

5.  Microdialysis evaluation of the ocular pharmacokinetics of propranolol in the conscious rabbit.

Authors:  K D Rittenhouse; R L Peiffer; G M Pollack
Journal:  Pharm Res       Date:  1999-05       Impact factor: 4.200

6.  Formulation, in vitro dissolution, and ocular bioavailability of high- and low-melting phenylephrine oxazolidines.

Authors:  Y Qiu; J K Guillory; R D Schoenwald
Journal:  Pharm Res       Date:  1993-11       Impact factor: 4.200

7.  Comparative study of the intraocular pressure effects of fluorometholone 0.1% versus dexamethasone 0.1%.

Authors:  A O Akingbehin
Journal:  Br J Ophthalmol       Date:  1983-10       Impact factor: 4.638

8.  Ocular and systemic bioavailability of ophthalmic flurbiprofen.

Authors:  D D Tang-Liu; S S Liu; R J Weinkam
Journal:  J Pharmacokinet Biopharm       Date:  1984-12

9.  Design and evaluation of novel fast forming pilocarpine-loaded ocular hydrogels for sustained pharmacological response.

Authors:  SivaNaga S Anumolu; Yashveer Singh; Dayuan Gao; Stanley Stein; Patrick J Sinko
Journal:  J Control Release       Date:  2009-03-31       Impact factor: 9.776

10.  Ocular Physiologically Based Pharmacokinetic Modeling for Ointment Formulations.

Authors:  Maxime Le Merdy; Jessica Spires; Viera Lukacova; Ming-Liang Tan; Andrew Babiskin; Xiaoming Xu; Liang Zhao; Michael B Bolger
Journal:  Pharm Res       Date:  2020-11-19       Impact factor: 4.200

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.